NEPH

NephrosC

Nasdaq / Capital Goods

At close

2026-07-22

Current thesis

Nephros exited 2025 with better revenue scale, profitability, and evidence of stronger programmatic demand, while management highlighted active-site growth and new-product expansion hooks [#10-K-2026-03-12][#IR-2025-11-07].

Posture

Mixed

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta 0.0.

What can break

Customer concentration remained high, with three customers representing 44% of 2025 revenue.

Momentum

Value

Sentiment

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $3.20 · Bull $4.40 · Bear $1.90

Data freshness

Prices

As of 2026-07-22

Fundamentals

As of 2026-07-22 • Vendor: Data Vendor v1

Scores

As of 2026-07-22 • Model: HYBRID_IC_RP

AI Memo

As of 2026-04-17 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-22

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net Neutral

Target $6.00

Why

Momentum72 · Δ7d -

Value56 · Δ7d 0.0

Sentiment35 · Δ7d -

So what

Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Lead driver: Value · See fundamentals

Momentum

26% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

39% active weight

Current posture

7d trendFlat

Δ7d

0.0

Δ21d

-1.6

Sentiment

34% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade C. Momentum 72.1 / Value 55.7 / Sentiment 35.4

Fundamentals (TTM)

As of 2026-07-22

Market Cap

$39.63M

Beta

1.40

Shares Out

10.86M

P/E (TTM)

35.4

P/S (TTM)

2.88

P/FCF (TTM)

18.99

Rev YoY

+6.9%

EPS YoY

-75.9%

Gross Margin

+59.3%

Op Margin

+8.1%

Net Debt

-$4.34M

Current Ratio

4.55

As of 2026-07-22 • Updated nightlySource: Internal modelMethodology